Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
Research Articles, Systems/Circuits

Neurons of the Central Nucleus of the Amygdala That Express Angiotensin Type 2 Receptors Couple Lowered Blood Pressure with Anxiolysis in Male Mice

Khalid Elsaafien, Matthew K. Kirchner, Karen A. Scott, Eliot A. Spector, Francesca E. Mowry, Colin Sumners, Javier E. Stern, Annette D. de Kloet and Eric G. Krause
Journal of Neuroscience 19 March 2025, 45 (12) e1482242025; https://doi.org/10.1523/JNEUROSCI.1482-24.2025
Khalid Elsaafien
1Neuroscience Institute, College of Arts and Sciences, Georgia State University, Atlanta, Georgia 30303
2Center for Neuroinflammation and Cardiometabolic Diseases, College of Arts and Sciences Georgia State University, Atlanta, Georgia 30303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew K. Kirchner
1Neuroscience Institute, College of Arts and Sciences, Georgia State University, Atlanta, Georgia 30303
2Center for Neuroinflammation and Cardiometabolic Diseases, College of Arts and Sciences Georgia State University, Atlanta, Georgia 30303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen A. Scott
1Neuroscience Institute, College of Arts and Sciences, Georgia State University, Atlanta, Georgia 30303
2Center for Neuroinflammation and Cardiometabolic Diseases, College of Arts and Sciences Georgia State University, Atlanta, Georgia 30303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Karen A. Scott
Eliot A. Spector
3Departments of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida 32610
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesca E. Mowry
1Neuroscience Institute, College of Arts and Sciences, Georgia State University, Atlanta, Georgia 30303
2Center for Neuroinflammation and Cardiometabolic Diseases, College of Arts and Sciences Georgia State University, Atlanta, Georgia 30303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colin Sumners
4Physiology and Aging, College of Medicine, University of Florida, Gainesville, Florida 32610
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier E. Stern
1Neuroscience Institute, College of Arts and Sciences, Georgia State University, Atlanta, Georgia 30303
2Center for Neuroinflammation and Cardiometabolic Diseases, College of Arts and Sciences Georgia State University, Atlanta, Georgia 30303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annette D. de Kloet
1Neuroscience Institute, College of Arts and Sciences, Georgia State University, Atlanta, Georgia 30303
2Center for Neuroinflammation and Cardiometabolic Diseases, College of Arts and Sciences Georgia State University, Atlanta, Georgia 30303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric G. Krause
1Neuroscience Institute, College of Arts and Sciences, Georgia State University, Atlanta, Georgia 30303
2Center for Neuroinflammation and Cardiometabolic Diseases, College of Arts and Sciences Georgia State University, Atlanta, Georgia 30303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • Peer Review
  • PDF
Loading

Abstract

Relief from psychological stress confers cardio-protection by altering brain activity and lowering blood pressure; however, the neuronal circuits orchestrating these effects are unknown. Here, we used male mice to discern neuronal circuits conferring stress relief and reduced blood pressure. We found that neurons residing in the central nucleus of the amygdala (CeA) expressing angiotensin type 2 receptors (AT2R), deemed CeAAT2R, innervate brain nuclei regulating stress responding. In vivo optogenetic excitation of CeAAT2R lowered blood pressure, and this effect was abrogated by systemic hexamethonium or antagonism of GABA receptors within the CeA. Intriguingly, in vivo optogenetic excitation of CeAAT2R was also potently anxiolytic. Delivery of an AT2R agonist into the CeA recapitulated the hypotensive and anxiolytic effects, but ablating AT2R(s) from the CeA was anxiogenic. The results suggest that the excitation of CeAAT2R couples lowered blood pressure with anxiolysis. The implication is that therapeutics targeting CeAAT2R may provide stress relief and protection against cardiovascular disease.

  • affective
  • autonomic
  • depression
  • hypertension
  • meditation
  • stress

Significance Statement

There is increasing appreciation that brain-to-body communication promotes susceptibility or resiliency to cardiovascular disease. Here, we present preclinical research that discerns a neural circuit that orchestrates brain-to-body communication and provides relief from mental stress. We discover that neurons within the central nucleus of the amygdala that express angiotensin type 2 receptors (hereafter referred to as CeAAT2R) are potent mediators of blood pressure and anxiolysis. The implication is that CeAAT2R or their angiotensin type 2 receptors can be targeted to protect against stress-induced cardiovascular disease.

Introduction

Cardiovascular disease is the leading cause of death in the United States (Curtin et al., 2023). The incidence of cardiovascular-related deaths steeply increased after the COVID-19 pandemic (Tsao et al., 2023), and this upward trajectory is projected to persist for decades (Mohebi et al., 2022). Thus, it is imperative to understand factors that drive pathogenesis or reversal of the disease. Psychological stress and hypertension are major contributors to the etiology of cardiovascular disease (Yusuf et al., 2004), and psychological stress creates changes in blood pressure and brain activity that predict pathogenesis (Ginty et al., 2017). Specifically, subjects that have increased activation of the amygdala and exaggerated elevations in blood pressure during psychological stress are more likely to experience cardiovascular disease events (Gianaros et al., 2008; Ginty et al., 2017; Tawakol et al., 2017). Interestingly, the inverse relationship is also true, and practices like meditation provide relief from psychological stress (Goyal et al., 2014), lower blood pressure (Chung et al., 2012; Palta et al., 2012), suppress activation of the amygdala (Kral et al., 2018), and protect against cardiovascular disease (Levine et al., 2017). While it is established that psychological stress impacts the amygdala to alter blood pressure, the underlying neural circuits are not well understood.

The renin-angiotensin-system (RAS) and its angiotensin type 1a (AT1aR) and type 2 (AT2R) receptors have long been implicated in blood pressure regulation and the development of cardiovascular disease. Angiotensin II (ANGII) is the effector peptide of the RAS, and it is generally accepted that overactivation of AT1aR promotes hypertension and cardiovascular disease (Chappell, 2016), but stimulation of AT2R opposes these deleterious effects (Steckelings et al., 2022). While much of the research on AT1aR and AT2R examines their effects on renal hemodynamics and/or peripheral vasoconstriction, each receptor subtype is also expressed within the brain (Sumners et al., 2020). Emerging preclinical studies using laboratory mice suggest that AT1aR and AT2R serve as phenotypic markers for neurons in the brain whose activity is coupled to emotional and cardiovascular responses to stress (Bregonzio et al., 2008; Wang et al., 2016; de Kloet et al., 2017; Elsaafien et al., 2021). For example, neurons within the central nucleus of the amygdala (CeA) express AT1aR (Mendelsohn et al., 1984; Gonzalez et al., 2012), the stimulation of which augments behavioral and cardiovascular responses to fearful stimuli (Davern et al., 2009; Yu et al., 2023). Intriguingly, AT2R(s) are also expressed in the CeA (de Kloet et al., 2016b) but their activation dampens stress responding (Yu et al., 2019). These prior reports suggest that neurons in the CeA that express angiotensin receptors can be manipulated to exacerbate or relieve psychological stress. Consequently, such neurons may comprise brain circuits that coordinate emotional and somatic responses to stress that influence the etiology of affective and cardiovascular disorders.

Here, we leverage neurons in the CeA that synthesize the AT2R (referred to as CeAAT2R) to delve deeply into brain circuits that lower blood pressure and relieve anxiety. Using mice genetically engineered to have enhanced green fluorescent protein (eGFP) or Cre-recombinase directed to cells that express AT2R, we conduct anatomical studies to reveal the neurochemistry and connectivity of CeAAT2R. Next, we use in vitro patch-clamp electrophysiology to evaluate how the selective AT2R agonist, compound 21 (C21), affects excitability of CeAAT2R. Corresponding in vivo experiments evaluate how central administration of C21 or optogenetic excitation of CeAAT2R affects blood pressure and anxiety-like behavior. Final experiments implement virally mediated gene transfer to ablate AT2R(s) within the CeA to determine whether these receptors contribute to basal levels of anxiety. Collectively, our results suggest that CeAAT2R are potent mediators of blood pressure and anxiety-like behavior. The implication is that therapeutics that activate CeAAT2R or their AT2R(s) may be ideally suited for alleviating hypertension and anxiety that manifests from heightened responses to psychological stress.

Materials and Methods

Animals

Studies were conducted in adult male mice on a C57BL/6J background. Mice were 8–10 weeks old at the initiation of the studies. All animals were maintained in temperature- and humidity-controlled rooms on 12 h light/dark cycles. In all cases, food and water were available ad libitum. All procedures were approved by the Institutional Animal Care and Use Committees at the University of Florida or Georgia State University and were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.

The AT2RCre knock-in mouse line was developed via the use of the CRISPR/Cas9 system by the University of Michigan. These mice were back-crossed onto a C57BL/6J background for 6+ generations upon arrival to the University of Florida (Mohammed et al., 2022). Of relevance, the Agtr2 gene is localized to the X-chromosome. Therefore, male mice were hemizygous for the AT2R-Cre gene (i.e., AT2RCre/y).

The AT2R reporter mouse line (AT2ReGFP) was initially generated by in vitro fertilization of FVB/NJ mice with Tg IP72Gsat mouse sperm (FVB/NTac × CD1(ICR) background) that was obtained from the Mutant Mouse Regional Resource Center (MMRC30278). Briefly, the construct used to produce the transgenic AT2ReGFP mouse line consists of an enhanced green fluorescent protein (eGFP) reporter gene and subsequent polyadenylation sequence that are inserted into the AT2R bacterial artificial chromosome (BAC) clone at the start codon of the first coding exon of the AT2R gene. This allows for eGFP expression that is driven by all of the regulatory sequences of the AT2R BAC gene. After successful in vitro fertilization, the AT2ReGFP reporter mouse line was back-crossed onto a C57BL/6J background for 10+ generations prior to their use in these studies. Importantly, these AT2ReGFP mice were previously validated in our laboratory by way of determining that neurons expressing eGFP are indeed neurons that synthesize Agtr2 mRNA(s) (de Kloet et al., 2016b).

Finally, the Cre/lox system was also utilized to selectively delete the Agtr2 gene from neurons within the CeA. To accomplish this, a knock-in mouse in which the first coding exon of the Agtr2 gene is surrounded by loxP sites was used (Welcome Trust Sanger Institute). These mice were provided by Drs. Ulrike Steckelings and Michael Bader and were back-crossed onto the congenic C57BL/6J strain for at least seven generations prior to their shipment (Mohammed et al., 2022). Upon arrival at the University of Florida, these mice were bred to a FLP deletor line (Jackson Laboratory Stock #011065) to remove the frt-flanked selection gene and then back-crossed onto the congenic C57BL/6J strain for an additional 6+ generations.

Viral constructs

Adeno-associated viral vectors (AAVs) that allow for the Cre-inducible expression of fluorophores (eYFPs) and/or the light-sensitive ion channel (ChR2) were obtained from the viral vector core at the University of North Carolina. For expression of eYFP and ChR2, pAAV2-EF1a-DIO-hChR2(H134R)-eYFP-WPRE (referred to as AAV-ChR2-eYFP) was used; for the expression of only eYFP, pAAV2-EF1a-DIO-eYFP (referred to as AAV-eYFP) was used. For the receptor deletion experiments, AAVs that allow for tdTomato (AAV-hSyn-dTom; referred to as tdTom) or Cre and tdTomato (AAV-hSyn-Cre-dTom; referred to as Cre-tdTom) were used.

Stereotaxic surgery

Stereotaxic surgery was performed to deliver AAVs into the central amygdala (CeA), to implant fiber optics targeting specific brain areas, and/or to implant ALZET osmotic minipumps and Brain Infusion kits (DURECT). Fiber optic implants allowed for optogenetic stimulation during cardiovascular recordings obtained under general anesthesia or during behavioral assays conducted in conscious freely moving mice, while ALZET osmotic minipumps and Brain Infusion kits (DURECT) were used to chronically deliver of C21 (7.5 ng/kg/h) or saline control into the lateral cerebral ventricle (i.c.v.) for 7 d.

In preparation for aseptic stereotaxic surgery, mice were anesthetized using isoflurane and administered analgesic (Buprenex; 0.1 mg·kg−1, s.c.). For AAV-mediated gene transfer to the CeA, Cre-inducible AAVs described above were injected bilaterally into the CeA using the following coordinates from bregma: AP: −1.4 mm, ML: ±2.75 mm, DV: −4.1 mm. For each AAV injection, the pipette was left in the region of interest for 5 min to allow for diffusion of the AAVs (100–150 nl) into the brain.

Following viral construct microinjections, a stereotactic frame was used to implant chronic dwelling fiber-optic posts terminating above the CeA using the following coordinates from bregma: AP: −1.4 mm, ML: ±2.75 mm, DV: −3.9 mm. Following that, the posts were secured in place using a skull screw and a dental acrylic as previously described (Elsaafien et al., 2021; Frazier et al., 2021).

The ALZET osmotic minipumps (model 1004; DURECT) and Brain Infusion kits (DURECT) were assembled and primed according to the manufacturer's instructions. After 48 h of priming at 37°C, the pumps were implanted subcutaneously in the intrascapular region, and the brain infusion kits were stereotactically directed to infuse C21 7.5 ng/kg/h (0.11 µl/h) or saline intracerebroventricularly using the following coordinates from the bregma: 0.2 mm posterior, 1.0 mm lateral, and 2.5 mm ventral (de Kloet et al., 2016a; Mohammed et al., 2022).

RNAscope in situ hybridization and immunohistochemistry

In order to collect tissue for neuroanatomical studies, mice were anesthetized with 0.1 ml of pentobarbital (50 mg·kg−1, i.p.) and perfused transcardially with RNase free-isotonic saline followed by 4% paraformaldehyde. Brains were then post-fixed for ∼4 h, after which they were stored in RNase-free 30% sucrose for up to 1 week before further processing. For RNAscope in situ hybridization (ISH), the CeA was sectioned at 20 µm into six serial sections using a Leica CM3050 S Cryostat (Leica). Sections were immediately mounted onto Fisherbrand Superfrost Plus Gold Microscope Slides (Thermo Fisher Scientific). After air-drying at room temperature for 20–30 min, slides were dipped in EtOH, again allowed to dry for 10–15 min, and then stored at −80°C until further processing.

RNAscope ISH was performed using the RNAscope V2 Multiplex Fluorescent Reagent Kit (Advanced Cell Diagnostics) as per the manufacturer's instructions with slight modification to the pretreatment procedure that allows for preservation of the reporter genes (i.e., eYFP), while still providing optimal mRNA signal. The probes used for these studies were as follows: Agtr2 (Mm-Agtr2; catalog #403991), vGAT (Mm-Slc32a1; catalog #319199), vGlut2 (Mm-Slc17a6-E1-E3; catalog #456759), DapB (Negative control probe-DapB; catalog #310043); and Ubc (Mm-Ubc; catalog #310771). Upon completion of the ISH, sections underwent IHC for GFP (used to amplify the eYFP signal).

Standard IHC protocols were used to amplify eYFP signal as previously described (de Kloet et al., 2017). Primary antibodies and dilutions used are as follows: GFP (Life Technologies [A10262]; 1:1,000). Secondary antibodies were purchased from Jackson ImmunoResearch, raised in donkey and used at a 1:500 dilution. Briefly, brain sections were rinsed and then incubated first in blocking solution (2% normal donkey serum and 0.2% Triton X-100 in 50 mM KPBS) for 2 h at 25°C and then in the primary antibody (diluted in blocking solution) for 18 h at 4°C. Sections were again rinsed five times for 5 min (50 mM KPBS) before incubation in the secondary antibody in blocking solution for 2 h at 25°C. After a final series of rinses, slides were allowed to air-dry and then coverslipped using ProLong Gold Antifade Mountant (Thermo Fisher Scientific).

Image capture and processing

Images were captured and processed using a laser scanning confocal microscope (Nikon Instruments). Large coronal scans captured at 10× magnification throughout the forebrain and hindbrain (coronal sections) were acquired to assess the expression of eYFP. For in situ hybridization, z-stacks of the proteins and mRNAs of interest were captured at 40× magnification. An average of 20 optical sections were collected per z-stack (0.5 µm between z-steps). Sections hybridized with the probes of interest were used to determine the exposure time and image processing required to provide optimal visualization of RNA signal. As described in detail previously (de Kloet et al., 2016b), these same parameters were then used to assess background fluorescence in sections hybridized with the negative control probe (DapB). Importantly, using these exposure times and image processing parameters, there was minimal or no fluorescence in sections hybridized with the negative control probe. All representative photomicrographs were then prepared using Adobe Photoshop 2023 to adjust brightness and contrast to provide optimal visualization. Final figures and schematics were prepared in Adobe Illustrator 2023.

Acute slice preparation

Male AT2RCre mice received stereotactic injections of the Cre-inducible AAV-ChR2-eYFP into the CeA as described above. AT2RCre or AT2ReGFP mice were anesthetized with 0.1 ml of pentobarbital (50 mg·kg−1, i.p.) and subsequently perfused through the heart with 30 ml of ice-cold aCSF sucrose solution with NaCl replaced by equal-osmol sucrose (in mM: 200 sucrose, 2.5 KCl, 1 MgSO4, 26 NaHCO3, 1.25 NaH2PO4, 20 d-glucose, 0.4 ascorbic acid, and 2.0 CaCl2; pH 7.2, 300–305 mOsmol·L−1). The brains were rapidly dissected, and the cerebellum was sliced cleanly with a razor blade and mounted in the chamber of a vibratome (Leica VT1200s, Leica Microsystems) using superglue with the ventral surface pressed against a block of 4% agar glued to the stage. The brain was submerged in sucrose slush and bubbled constantly with 95% O2/5% CO2. Coronal slices (240 µm thickness) containing the CeA were collected and placed in a holding chamber filled with aCSF and bubbled with 95% O2/5% CO2. The aCSF is identical in composition to the sucrose solution, but with 200 mM sucrose replaced by 119 mM NaCl and 2 mM Na+-pyruvate. The slice chamber was placed in a water bath at 32°C for 20 min before placement at room temperature for a total minimum of 60 min rest before proceeding with recording.

Patch-clamp electrophysiology

Slices were placed into a chamber on the stage of a Nikon upright microscope and perfused constantly (2–3 ml/min) with aCSF bubbled continuously with 95% O2/5% CO2 and warmed to 32°C. CeAAT2R neurons containing eGFP or eYFP and ChR2 were visualized using the Dragonfly 200 laser spinning disk confocal imaging system and an iXon 888 EMCCD camera (Andor Technology). Neurons were targeted for patch clamp that were in close proximity to YFP-labeled somas and processes. Whole-cell voltage-clamp recordings were obtained using pipettes (2.5–4 MΩ) pulled from borosilicate glass (o.d. 1.5 mm, i.d. 1.17) using a P-97 Flaming/Brown horizontal micropipette puller (Sutter Instrument). To measure and amplify GABA synaptic currents, we utilized a high Cl− internal solution consisting of the following (in mM): 145 KCl, 10 HEPES, 0.9 MgCl2, 4 Mg-ATP, 0.3 Na-GTP, 6 phosphocreatine, 0.2 EGTA with pH 7.2–7.3 and 285–295 mOsmol (kg·H2O)−1. The liquid junction potential for the KCl internal was approximately +2 mV and was not corrected. Occasionally, Alexa 555 (50 μM, Thermo Fisher Scientific) was included to visualize the neuron. For voltage-clamp recordings, traces were obtained with a MultiClamp 700B amplifier (Molecular Devices) and digitized using an Axon 1440B Digitizer (Molecular Devices) at 2 kHz on a desktop computer running Clampex 10 software (Molecular Devices). Cells were clamped at −70 mV unless otherwise indicated. Data were discarded if series resistance exceeded a 25% change over the course of the recording.

Stimulating eGFP neurons pharmacologically was done through the bath application of compound 21 at 0.5 μM via a single bolus bath injection (0.5 ml) into the bath as previously described (de Kloet et al., 2016a). Mean firing activity was calculated from a 1 min period before drug application and a 1 min period around the peak effect.

ChR2 stimulation was driven by an Andor Mosaic and iQ3/Fusion integration at 488 nm using 20 ms pulses with 80 ms interpulse intervals (10 Hz). The entire field of view was stimulated. Picrotoxin (Px, 100 µM; Tocris) via a single bolus bath injection (0.5 ml) into the bath to block GABA currents.

Anesthetized assessment of blood pressure in response to optogenetic manipulations

Male AT2RCre mice received stereotaxic injections of the Cre-inducible AAV-ChR2-eYFP or AAV-eYFP into the CeA as described above. Three to four weeks later, mice were anesthetized using isoflurane and a Millar Catheter (Model SPR1000, Millar) was implanted into the aortic arch by way of the carotid artery using a similar procedure as described previously (de Kloet et al., 2017; Elsaafien et al., 2021, 2022). After catheterization, mice underwent stereotaxic surgery to lower a fiber optic into the CeA, BNST, PAG, or cNTS for optical stimulation.

To collect cardiovascular data, the Millar Catheter was connected to a PowerLab signal transduction unit (ADInstruments). Blood pressure and heart rate data were sampled/recorded at 1 kHz and analyzed using LabChart 8 software (ADInstruments). To test the effect of optical stimulation on blood pressure, mice were optically stimulated with 473 nm blue light for 60 s (10 mW output; 20 ms pulse width) at 1, 15, and 30 Hz. Mice then received injections of 0.1 ml of hexamethonium (30 mg/kg, i.p.) or saline vehicle. Once blood pressure again stabilized (∼15–20 min after the injections), mice were again subjected to optical stimulation using the same parameters. Blood pressure data were condensed into 30 s bins to perform statistical analyses and to generate the figures.

Anesthetized assessment of blood pressure in response to pharmacological injections

In a different set of experiments, AT2RCre mice received stereotaxic injections of the Cre-inducible AAV-ChR2-eYFP into the CeA, and following 3 weeks of recovery, mice were anesthetized, and a Millar Catheter (Model SPR1000, Millar) was implanted into the aortic arch. Subsequently, a dual optical injector cannula (Optical Injector, Doric Lenses) was lowered above the left CeA, allowing microinjections and optogenetic stimulation within the same site while blood pressure was simultaneously recorded, as described previously (Elsaafien et al., 2021). Either vehicle (43% ethyl alcohol, 43% dH2O, 14% trifluoroacetic acid; 1 μl) or bicuculline (10 mM; 1 μl) were microinjected and pulses of 473 nm laser light (10 mW output; 20 ms pulse width; 30 Hz; 5 min) were delivered 10 min following microinjections. Blood pressure was sampled at 30 s every 60 s for 2 and 5 min prior to and following optical stimulation, respectively.

Spectral analysis of heart rate and systolic blood pressure variability

Heart rate variability (HRV) was analyzed using a Heart Rate Variability Analysis Software provided in LabChart 8 (ADInstruments), whereas systolic blood pressure variability was analyzed using a fast Fourier transform spectral variation in systolic blood pressure using LabChart 8. Briefly, HRV and systolic blood pressure variability were sampled at 1 min bins prior to and following optogenetic stimulation, and the frequency bands were very low frequency (VLF), low frequency (LF), and high frequency (HF) at 0–0.15, 0.15–1.5, and 1.5–5 Hz, respectively. HRV was expressed as a of LF/HF ratio, which is a surrogate clinical marker of sympatho-vagal balance to the heart (Tasic et al., 2017). The low frequency domain of systolic blood pressure variability indicates the level of sympathetic vasoconstrictor activity (deBoer et al., 1987; Madwed et al., 1989).

Assessment of anxiety-like behavior

Anxiety-like behavior was assessed during the light phase (between 08:00 A.M. and 12:00 P.M.), in mice that were chronically delivered C21 or saline intracerebroventricularly, mice that were subjected to optogenetic stimulation of CeAAT2R, and mice with deletion of CeA AT2R(s), as well as their respective controls. Mice underwent stereotaxic surgical procedures and were allowed to recover for at least 7 d, as described above, prior to testing. For the optogenetics studies, mice also underwent a 2 week period of habituation to the optogenetic tethering procedure prior to initiating behavioral testing.

Elevated plus maze test

The elevated plus maze (EPM) arena has two opposing open arms and two opposing closed arms, raised 61 cm above the floor. All arms are 35 × 5 cm (l × w) with white floors, and the walls of the closed arms are made of black polycarbonate, 20 cm high. When the test was performed during optogenetic stimulation of CeAAT2R, each mouse was brought into the procedure room and tethered to the laser for 5 min within the home cage prior to the onset of the test. The mouse was then placed in the center of the EPM, facing an open arm, and optogenetic stimulation began (10 mW, 15 Hz, 20 ms pulses, 75 pulses per sequence, 5 s delay between sequences). The total duration of the test and the optogenetic stimulation was 5 min. Results, including the percentage of time spent in the open arms, the percentage of time spent in the closed arms, and the distance traveled, were recorded and analyzed by EthoVision XT 13 (Noldus Information Technology). For mice implanted with osmotic minipumps and brain infusion kits and for mice with deletion of CeA AT2R, the same procedures were performed but without tethering or optogenetic stimulation.

Open field arena test

The open field arena (OFA) test was conducted in a 45 × 45 × 30 cm (l × w × h) square arena constructed of white plastic floor and walls. When the test was performed with optogenetic stimulation, each mouse was brought into the procedure room and tethered to the laser for 5 min within the home cage prior to the onset of the test. The mouse was then placed in the center of the OFA and optogenetic stimulation began (10 mW, 15 Hz, 20 ms pulses, 75 pulses per sequence, 5 s delay between sequences), after which the mouse was untethered and returned to their home cage. Results, including total distance traveled and entries into center (located in the center of arena with 50% of total area) or edge, were recorded and analyzed using EthoVision XT 13 software (Noldus Information Technology). For mice with deletion of CeA AT2R, the same procedures were performed but without tethering or optogenetic stimulation.

Novelty-induced suppression of feeding (graham cracker test)

In order to perform the graham cracker test (GCT), mice first underwent a period of habituation, during which a small dish with ∼0.2 g graham cracker crumbs was placed in the home cage of the mouse. Mice had access to the crumbs for up to 15 min per day (1 session per day) until the latency to approach and consume the crumbs during the session was consistent (up to 10 d in a row). On the test day, the mouse was taken to the behavioral room, tethered to the laser in the home cage for 5 min, and then placed into a novel cage with access to a small dish with graham cracker crumbs. Optogenetic stimulation (10 mW, 15 Hz, 20 ms pulses, 75 pulses per sequence, 5 s delay between sequences) began when the mouse was placed into the novel cage. The latency to approach and consume the crumbs in the novel environment was then recorded as a measure of anxiety in a novel environment. The mouse was untethered and returned to its home cage following the 15 min test. For tests of mice with deletion of CeA AT2R, the same procedures were performed but without tethering or optogenetic stimulation.

Statistics

Quantification of immunohistochemical data was done in FIJI. For these data, as well as the behavioral data, unpaired Student's t tests were performed in GraphPad to determine significance. p < 0.05 (one-tailed) was considered significant.

Gap-free voltage-clamp recordings were low-pass filtered at 2 kHz. Evoked IPSCs were loaded into a custom program (https://www.researchgate.net/publication/338623194_NeuroExpress_program_for_analyzing_patch-clamp_data; NeuroExpress, Attila Szücs, Eötvös Loránd University; Hernáth et al., 2019; Rátkai et al., 2021). Noise threshold was set on a per cell basis using an average of the noise bandwidth (8–15 pA). IPSC detection threshold was set to 20 pA. Statistical analyses and graphs were generated using Prism version 9.1.0 (GraphPad Software). Example gap-free recordings generated using Igor Pro (WaveMetrics). A paired t test was used to compare ChR2-evoked IPSC amplitudes between holding potentials and before and after picrotoxin application. p < 0.05 was considered significant.

Cardiovascular parameters obtained from anesthetized mice were analyzed in LabChart 8 (ADInstruments). For all cardiovascular parameters, two-way ANOVAs with Šídák's multiple-comparisons tests were performed using GraphPad to determine significance.

All values are reported as mean ± standard error of the mean (SEM). Statistical analyses and graphs were generated using Prism version 9.1.0 (GraphPad Software).

Results

CeAAT2R connect to fore-, mid-, and hindbrain nuclei mediating autonomic outflow and stress reactivity but are primarily GABAergic

We delivered a Cre-inducible AAV synthesizing enhanced yellow fluorescent protein (eYFP) into the CeA of AT2RCre mice to visualize neurons that express AT2R(s) (Fig. 1A). Two to three weeks later, mice were perfused, brains were extracted, and sections through the CeA were processed for RNAscope in situ hybridization for Agtr2 mRNA(s) and immunohistochemistry for eYFP. Photomicrographs obtained at low power magnification found bilateral expression of eYFP within the CeA (Fig. 1B). Quantification of higher magnification images revealed that mRNA(s) encoding AT2R(s) were present within ≈90% of eYFP-labeled cells (Fig. 1C). To gain insight on how stimulation of AT2R affects the excitability of neurons, we utilized AT2ReGFP mice to obtain in vitro patch-clamp electrophysiological recordings from CeAAT2R during bath application of the specific AT2R agonist, C21 at 0.5 μM/0.5 ml (Steckelings et al., 2011). Consistent with prior reports (Zhu et al., 2001; de Kloet et al., 2016a), application of C21 significantly (p = 0.031 Wilcoxon test, n = 7) increased the firing rates in 7 of 9 neurons sampled (Fig. 1D). Collectively, these results demonstrate that Cre-recombination is directed to AT2R gene expression with the same high fidelity that we previously observed (Mohammed et al., 2022) and that stimulation of AT2R(s) elicits firing of CeAAT2R.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Genetic targeting of CeAAT2R. A, Schematics depicting the bilateral injections of a Cre- inducible AAVs into the CeA of AT2RCre mice to direct the expression of eYFP to neurons that express AT2R. B, A confocal coronal scan through the CeA demonstrating the localization of eYFP in the CeA. C, A representative image depicting the colocalization of Agtr2 mRNA to eYFP-labeled neurons in the CeA, and a bar chart of colocalization quantification. D, Top, A schematic depicting electrophysiological recordings from brain slices obtained from AT2ReGFP mice, middle, representative image of an eGFP-labeled neuron targeted for patch-clamp recordings (scale bar, 20 µm); bottom, responses to the 0.5 ml bath application of 0.5 µM C21. C21 increased action potential firing in 7/9 cells. *p < 0.05, n = 7; Wilcoxon test.

Next, we performed confocal scans of brain sections obtained from AT2RCre mice administered Cre-inducible AAV-eYFP into the CeA (Fig. 2A). These scans revealed densely labeled somas at the site of injection, as well as eYFP-labeled axons with projections that traverse the fore-, mid-, and hindbrain (Fig. 2B). Immunohistochemistry for eYFP performed on coronal brain sections confirmed the appearance of axon terminals in the bed nucleus of the stria terminalis (BNST), periaqueductal gray (PAG), and caudal nucleus of the solitary tract (cNTS; Fig. 2B, Table 1). Results from these tract-tracing experiments indicate that CeAAT2R are connected to brain nuclei implicated in autonomic outflow and stress reactivity. To ascertain the neurochemical phenotype of CeAAT2R, we performed immunohistochemistry for eYFP with RNAscope in situ hybridization for mRNA(s) encoding vesicular GABA transporter (vGAT) or vesicular glutamate transporter 2 (vGlut2), markers for GABAergic or glutamatergic neurons, respectively. As shown in Figure 2C–E, ≈90% of eYFP-labeled cells expressed vGAT mRNA but only ≈9% of such cells were found to express vGlut2 mRNA. Collectively, these results suggest that while CeAAT2R likely form local connections within the amygdala, they also send long range axonal projections to distal nuclei; however, the majority of CeAAT2R are GABAergic.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Anatomical phenotyping of CeAAT2R. A, Schematics depicting the bilateral injections of a Cre-inducible AAV synthesizing eYFP into the CeA of AT2RCre mice. B, Confocal coronal scans through the forebrain and hindbrain demonstrating somas within the CeA and fibers projecting throughout the fore-, mid-, and hindbrain. Representative image depicting the colocalization of vGAT mRNA (C) or vGlut2 (D) within eYFP-labeled neurons in the CeA. E, Bar chart of colocalization quantification.

View this table:
  • View inline
  • View popup
Table 1.

Fiber projections of CeAAT2R throughout the brain

Excitation of CeAAT2R lowers blood pressure and this effect is mediated by the autonomic nervous system

The structural connectivity exhibited by CeAAT2R predicts that such neurons function as mediators of autonomic outflow. To begin to test this prediction, we recorded blood pressure and heart rate during acute delivery of C21 into the CeA. Mice were anesthetized and a Millar Catheter was implanted into the left common carotid artery. Mice were then placed in a stereotaxic frame, a microcraniotomy was performed, and C21 (22 ng/1 μl) was bilaterally microinjected into the CeA and cardiovascular parameters were recorded (Fig. 3A). As shown in Figure 3A, relative to controls administered saline, delivery of C21 significantly and transiently decreased blood pressure (F(26,324) = 1.2, p < 0.0001; two-way ANOVA followed by Šídák post hoc test, n = 7) but had no effect on heart rate (F(26,324) = 1.3, p = 0.1857; two-way ANOVA followed by Šídák post hoc test, n = 7).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Excitation of CeAAT2R decreases blood pressure. A, Top, Schematic depicting cardiovascular recording while bilaterally microinjecting saline or C21 (22 ng/1 µl) into the CeA of C57BL/6J mice; bottom, group data depicting systolic blood pressure (SBP) and heart rate (HR) upon the microinjection of saline or C21 into the CeA. B, Top, A schematic depicting electrophysiological recordings from brain slices obtained from AT2RCre mice injected with Cre-dependent ChR2. Middle, Image depicting a patched CeAAT2R expressing ChR2/eYFP and loaded with Alexa 555 dye (scale bar, 20 µm). Bottom, Current-clamp recordings demonstrating action potentials in response to single and repetitive stimulation with 488 nm blue light. C, Top, Schematic of the opto-cardio preparation in AT2RCre mice that received Cre-inducible AAV that directs the expression of eYFP (control; red) and/or ChR2 (experimental; blue) to AT2R-expressing cells within the CeA. Bottom: representative traces showing the blood pressure response to 473 nm blue light illumination of CeAAT2R in the control and experimental groups. Group data depicting (D) SBP and HR, (E) very low frequency (VLF-SBP) and low frequency (LF-SBP) systolic blood pressure variability, (F) SBP prior to or following the administration of 0.1 ml of hexamethonium (30 mg/kg, i.p.) with optical stimulation (473 nm, 20 ms pulse width at 10 mW for 1 min). Blue box represents period of 473 nm light illumination (15 Hz for C, E, F, 1, 15 and 30 Hz for D). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.001; two-way ANOVA followed by Šídák post hoc test, †p < 0.05, ††p < 0.01, †††p < 0.001, ††††p < 0.001; repeated-measures two-way ANOVA. n = 4–10.

To gain further insight on the role that CeAAT2R play in this hypotensive response, we used optogenetics to evaluate whether excitation of CeAAT2R alters cardiovascular function. Cre-inducible AAVs, synthesizing eYFP only (control) or the light-sensitive ion channel, channelrhodopsin-2 (ChR2) and eYFP, were bilaterally administered into the CeA of AT2RCre mice (Fig. 3B). Two to three weeks later, a subset of mice was killed, and coronal sections through the CeA were used to verify ChR2 function in CeAAT2R using in vitro whole-cell voltage-clamp electrophysiological recordings. Recordings obtained from CeAAT2R found that optogenetic stimulation with varying protocols of 488 nm light pulses reliably evoked action potentials in the patched neurons, demonstrating the expression of functional opsins (Fig. 3B).

In vivo optogenetic experiments evaluated whether excitation of CeAAT2R affected blood pressure and heart rate. Mice were anesthetized and a Millar Catheter was implanted into the left common carotid artery. Mice were then placed in a stereotaxic frame, a microcraniotomy was performed, fiber optics connected to a laser light source were bilaterally inserted into the CeA, and pulses of 488 nm light were delivered to CeAAT2R while cardiovascular parameters were recorded (Fig. 3C). Relative to controls expressing only eYFP, optogenetic excitation of CeAAT2R with ChR2 significantly reduced blood pressure when pulses of 488 nm light were delivered at 15 Hz (F(14,238) = 4.05, p < 0.0001; two-way ANOVA followed by Šídák post hoc test, n = 8–10) or 30 Hz (F(16,164) = 2.4, p = 0.0043; two-way ANOVA followed by Šídák post hoc test, n = 6–7; Fig. 3C,D); however, the heart rate responses to optical stimulation were similar among the groups (15 Hz; F(14,238) = 0.6, p = 0.8674, 30 Hz; F(16,164) = 0.19, p = 0.9995; two-way ANOVA followed by Šídák post hoc test, n = 6–10; Fig. 3D). To gain insight on whether the reductions in blood pressure were associated with altered sympathetic and/or parasympathetic outflow to the vasculature, we conducted systolic blood pressure variability analyses. As shown by Figure 3E, relative to controls, optogenetic excitation of CeAAT2R significantly decreased the low frequency domain of systolic blood pressure variability (F(7,120) = 1.9, p < 0.0001; two-way ANOVA followed by Šídák post hoc test, n = 8–9). This suggests that excitation of CeAAT2R alters autonomic outflow to the vasculature by promoting sympathetic withdrawal and/or enhancing vagal tone. Finally, we systemically administered mice the nicotinic receptor antagonist, hexamethonium (0.1 ml at 30 mg/kg, i.p.), to determine whether the decrease in blood pressure that occurs with in vivo optogenetic excitation of CeAAT2R is mediated by the autonomic nervous system. As before, optogenetic excitation of CeAAT2R significantly decreased systolic blood pressure in mice expressing ChR2 relative to controls; however, this effect was completely abolished after administration of hexamethonium (F(42,371) = 2.6, p < 0.0001; two-way ANOVA followed by Tukey's post hoc test, n = 5–10; Fig. 3F). Taken together, these results suggest that excitation of CeAATR2 decreases blood pressure by suppressing sympathetic outflow and/or augmenting vagal tone.

Optogenetic excitation of distal projections originating from CeAAT2R does not lower blood pressure

Our tract-tracing and in vivo optogenetic experiments revealed that CeAAT2R send projections to brain nuclei that mediate autonomic outflow to cardiovascular tissues. Consequently, we performed follow-up experiments to test the prediction that optogenetic excitation of axonal projections originating from CeAAT2R would recapitulate the lowered blood pressure that was observed. We again bilaterally delivered Cre-inducible AAV(s) synthesizing eYFP or eYFP and ChR2 into the CeA of AT2RCre mice. Two to three weeks later, mice were anesthetized, implanted with a Millar Catheter, and placed in a stereotaxic frame, and a microcraniotomy was performed as done in the previous experiment. However, instead of delivering optical stimulation to the CeA, fiber optics now targeted axonal projections presumed to terminate in the BNST, PAG, and cNTS. Optogenetic stimulation of the BNST (15 Hz: −1.1 ± 0.5 vs −0.50 ± 0.5 mmHg; F(14,118) = 1.1, p = 0.4147, 30 Hz: −1.4 ± 1.5 vs −1.1 ± 0.67 mmHg; F(14,118) = 0.4, p = 0.9598; two-way ANOVA followed by Šídák post hoc test, n = 4–6) and PAG (15 Hz: −2.4 ± 1.5 vs −0.62 ± 1.0 mmHg; F(14,120) = 0.2, p = 0.9993, 30 Hz: −0.8 ± 0.4 vs −2.3 ± 3.3 mmHg; F(14,120) = 0.5, p = 0.9625; two-way ANOVA followed by Šídák post hoc test, n = 4–6) had no effects on blood pressure. In addition, and contrary to our prediction, activating axonal fibers in the cNTS that originated from CeAAT2R significantly elevated blood pressure (15 Hz; F(14,139) = 1.9, p = 0.0295, 30 Hz; F(14,131) = 2.0, p = 0.0203; two-way ANOVA followed by Šídák post hoc test, n = 4–8; Fig. 4). Like the prior experiment, differences in heart rate were not observed (15 Hz: −0.9 ± 0.5 vs −1.7 ± 0.6 bpm; F(14,139) = 1.1, p = 0.3671, 30 Hz: −1.9 ± 0.8 vs 0.6 ± 1.3 bpm; F(14,131) = 0.6, p = 0.8873; two-way ANOVA followed by Šídák post hoc test, n = 4–8; Fig. 4B). These results suggest that connections from CeAAT2R to distal brain nuclei may not contribute to the decreased blood pressure that was observed, but rather, this effect may be mediated by synaptic connections localized to the CeA.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Excitation of CeAAT2R fibers projecting to the NTS increase blood pressure. A, Schematic depicting the optogenetics-cardiovascular preparation in male AT2RCre mice that received Cre-inducible AAV to direct the expression of eYFP (control; red) and/or ChR2 (experimental; blue) to CeAAT2R. B, Top, Schematic depicting in vivo optogenetic stimulation of fibers originating from CeAAT2R; middle, representative traces of the blood pressure response during 473 nm blue light illumination (473 nm, 15 Hz, 20 ms pulse width at 10 mW for 5 min; 1 min ON/OFF); bottom, group data showing systolic blood pressure (SBP) and heart rate (HR) prior to and during 473 nm blue light illumination. Blue box represents period of 473 nm light illumination. *p < 0.05, ****p < 0.001; two-way ANOVA followed by Šídák post hoc test. n = 4–8.

In vitro optogenetic excitation of CeAAT2R stimulates GABA receptors on neighboring neurons, an effect that is required for the lowered blood pressure that follows in vivo optogenetic excitation of CeAAT2R

Because exciting sites distal to the CeA yielded null results or produced results contrary to those anticipated, we undertook experiments examining whether excitation of CeAAT2R engages local circuits to promote a hypotensive response. The Cre-inducible AAV synthesizing eYFP and ChR2 was again injected into the CeA of AT2RCre mice. Two to three weeks later, mice were killed, and live brain slices were used for in vitro optogenetic experiments examining local synaptic connections made by CeAAT2R. Using a combination of epifluorescence and DIC microscopy, patch-clamp electrophysiological recordings were obtained from CeA neurons that were devoid of eYFP labeling but were near eYFP/ChR2 expressing fibers originating from CeAAT2R (Fig. 5A). Delivery of 488 nm light (10 Hz for 2 s) evoked inhibitory postsynaptic currents (IPSCs) in all non-CeAAT2R patched neurons. To confirm the GABAergic nature of these synaptic events, we stimulated the ChR2 before and after the 0.5 ml bath application of the GABAA channel blocker picrotoxin (100 µM), demonstrating a significant reduction in current amplitude (p = 0.0313 Wilcoxon test, n = 6). Additionally, shifting the holding potential (Vh) from −70 to −60 mV, bringing it closer to the Cl− reversal potential, reliably reduced the amplitude of these evoked synaptic events (p = 0.125 Wilcoxon test, n = 4; Fig. 5B). The lack of a sustained inward current following the light stimulation in the patched neurons further confirmed their identity as non-CeAAT2R neurons. Collectively, these results demonstrate that CeAAT2R exert inhibition over neighboring non-CeAAT2R neurons via the local release of GABA.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Excitation of CeAAT2R evokes local GABA release that lowers blood pressure. A, Schematic depicting the electrophysiological preparation of brain slices obtained from AT2RCre mice that received Cre-inducible AAV directing the expression of eYFP and ChR2 to CeAAT2R. B, Voltage-clamp recordings of nonlabeled neurons in close proximity to ChR2-eYFP-labeled neurons. Whole field 488 nm light pulses evoked instantaneous IPSCs, indicating synaptic innervation by CeAAT2R neurons. Subsequent 0.5 ml bath application of 100 μM picrotoxin significantly reduces the amplitude of evoked IPSCs to 488 nm light pulses *p < 0.05; Wilcoxon test. n = 6. Additionally, shifting the holding potential (Vh) from −70 to −60 mV consistently reduces amplitude of evoked IPSCs to 488 nm light pulses. p = 0.13; Wilcoxon test. n = 4. C, Schematic showing optogenetic excitation with microinjection of bicuculline. D, Group data demonstrating systolic blood pressure (SBP) and heart rate (HR) upon the microinjection of vehicle (43% ethyl alcohol, 43% dH2O, 14% trifluoroacetic acid) or bicuculline (30 mM/1 μl) into the CeA. E, Group data showing SBP and HR during optical stimulation (473 nm, 30 Hz, 20 ms pulse width at 10 mW for 5 min; 1 min ON/OFF) in control and experimental mice treated with vehicle or bicuculline. Blue box represents period of 473 nm light illumination. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.001; two-way ANOVA followed by Šídák post hoc test, ††p < 0.01, †††p < 0.001; repeated-measures two-way ANOVA. n = 4–7.

Next, we combined neuropharmacology with in vivo optogenetics and cardiovascular recordings to determine whether activation of GABA receptors localized to the CeA is required for the lowered blood pressure that follows excitation of CeAAT2R. Cre-inducible viruses were unilaterally delivered into the CeA of AT2RCre mice, and 2–3 weeks later, mice were prepared for cardiovascular recordings during optogenetic excitation of CeAAT2R. The methodology was like our previous experiments; however, optogenetic excitation was accomplished using a dual fiber-optic cannula that allows pulses of 488 nm light and microinjection of fluid to be delivered simultaneously to the target nuclei (Elsaafien et al., 2021; Fig. 5C). Consistent with prior reports (Ciriello and Roder, 1999; Zhang et al., 2009), microinjection of the GABAA receptor antagonist, bicuculline (10 mM/1 μl), into the CeA produced a significant but transient increase in blood pressure when compared with injection of the vehicle control (F(12,143) = 2.0, p = 0.0334; two-way ANOVA followed by Šídák post hoc test, n = 6–7; Fig. 5D). Taking this effect into account, we next tested optogenetic excitation of CeAAT2R after the pressor effects of bicuculline had subsided (e.g., ≈10 min post-bicuculline injection). Figure 5E shows the effect of optical stimulation on blood pressure in AT2RCre mice given the control AAV or an AAV expressing ChR2 after delivery of vehicle or bicuculline. As expected, optical stimulation of CeAAT2R significantly decreased blood pressure in mice expressing ChR2 when compared with controls; however, administration of bicuculline 10 min prior to optogenetic excitation of CeAAT2R completely abolished this effect (F(42,210) = 1.8, p = 0.0043; two-way ANOVA followed by Tukey's post hoc test, n = 4–5; Fig. 5E). These collective results suggest that excitation of CeAAT2R evokes the release of GABA, which acts on GABAA receptors expressed on neighboring neurons to decrease blood pressure.

Central AT2R activation or optogenetic excitation of CeAAT2R suppresses, but ablating AT2R(s) within the CeA incites anxiety-like behavior

The structure and synaptic connectivity exhibited by CeAAT2R predicts that such neurons function as mediators of stress reactivity. To begin to test this prediction, we outfitted wild-type C57BL/6J mice with mini-osmotic pumps that allow chronic infusion of the AT2R agonist, C21 (7.5 ng/kg/h), into the lateral ventricle. Subsequently, mice were tested in an EPM to determine whether activation of AT2R(s) within the brain may affect anxiety-like behavior. As shown in Figure 6, relative to saline-infused controls, chronic stimulation of brain-dwelling AT2R(s) increased the amount of time that mice spent in the open arms of the EPM (t(21) = 2.675, p = 0.0071; unpaired t test, n = 11–12) while decreasing the time spent in the closed arms (t(21) = 2.022, p = 0.028; unpaired t test, n = 11–12) and not affecting the total distance traveled (t(21) = 0.55, p = 0.294; unpaired t test, n = 11–12). These results suggest that stimulating AT2R(s) within the brain is sufficient to attenuate anxiety-like behavior.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Activation of central AT2R(s) is anxiolytic. A, Top, Schematic depicting osmotic minipumps infusing saline or C21 (7.5 ng/kg/h) into the lateral ventricles (bottom) prior to testing in the EPM. Right, Bar graphs demonstrating % of time spent in the (B) open or (C) closed arms of the maze and (D) the total distance traveled. *p < 0.05, **p < 0.01; unpaired student t test. n = 11–12.

Follow-up experiments utilized in vivo optogenetics to evaluate whether selective excitation of CeAAT2R recapitulates the anxiolytic effects of stimulating central AT2R(s). Cre-inducible AAVs synthesizing eYFP or eYFP and ChR2 were bilaterally administered into the CeA of AT2RCre mice. Following administration of AAV(s), mice were bilaterally implanted with chronic dwelling fiber optics targeting the CeA (Fig. 7A). Two to three weeks later, we initiated in vivo optogenetic experiments evaluating whether excitation of CeAAT2R affected anxiety-like behavior as assessed with the EPM, OFA, and a novelty suppressed feeding paradigm (i.e., GCT). Relative to controls, optogenetic excitation of CeAAT2R significantly increased the amount of time mice spent in the open (t(14) = 3.2, p = 0.0070, unpaired t test, n = 7–9), but decreased time spent in the closed (t(15) = 3.0, p = 0.0088, unpaired t test, n = 8–9), arms of the EPM (Fig. 7B). Consistent with these results, optogenetic excitation of CeAAT2R also significantly increased the amount of time mice spent in the center of the OFA (t(10) = 2.0, p = 0.0401, unpaired t test, n = 7–9) and decreased the latency to eat (t(7) = 2.8, p = 0.0259, unpaired t test, n = 4–5) in the GCT (Fig. 7C,D). Importantly, control mice and those expressing ChR2 traveled similar distances in the EPM (t(14) = 0.1, p = 0.8887, unpaired t test, n = 7–9) and OFA (t(14) = 0.6, p = 0.5816, unpaired t test, n = 7–9) during optical stimulation (Fig. 7B,C), indicating that the anxiolytic effects of exciting CeAAT2R are likely not attributed to alterations in locomotor activity. Taken together, these results suggest that like central AT2R stimulation, excitation of CeAAT2R is anxiolytic in male mice.

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

The optogenetic excitation of CeAAT2R is anxiolytic. A, Schematic depicting AT2RCre mice that received Cre-inducible AAV to direct the expression of eYFP (control; red) and/or ChR2 (experimental; blue) to CeAAT2R. Subsequently, mice were bilaterally implanted with chronic dwelling fiber optic targeting the CeA. Optogenetic stimulation of CeAAT2R during an (B) EPM, (C) OFA, and (D) GCT in control and experimental mice. Optical stimulation: 473 nm, 15 Hz, 20 ms pulse width at 10 mW for 5 min; 75 pulses per sequence; 5 s delay between sequences. *p < 0.05, **p < 0.01; unpaired student t test. n = 4–9/group.

While the results from our pharmacological and optogenetic experiments suggest that excitation of CeAAT2R is sufficient to alter anxiety-like behavior, they do not evaluate the necessity of AT2R(s), per se. To determine whether AT2R(s) localized to the amygdala contribute to basal levels of anxiety-like behavior, we bilaterally administered an AAV expressing Cre-recombinase and tdTomato into the CeA of mice with LoxP sites flanking the AT2R gene (AT2Rflox mice; Fig. 8A). This approach allows deletion of AT2R(s) from cells residing in the CeA. AT2Rflox mice delivered an AAV only expressing tdTomato served as controls. To confirm deletion of AT2R(s), a subset of mice was killed and perfused, and extracted brains were processed for RNAscope in situ hybridization for AT2R mRNA(s). Figure 8B depicts site-specific viral delivery as demonstrated by tdTomato expression localized to the CeA. Relative to controls, AT2Rflox mice given AAV expressing Cre-recombinase had significantly fewer tdTomato-labeled cells expressing AT2R mRNA(s) (tdTom: 19.5 ± 3.0 vs Cre-tdTom: 0.02 ± 0.01%, t(4) = 6.559 p = 0.0028, unpaired t test, n = 3; Fig. 8C). Importantly, control mice and those expressing Cre-recombinase had similar expression of AT2R mRNA(s) within DAPI-labeled cells in the medial amygdala (tdTom: 8.6 ± 3.1 vs Cre-tdTom: 12.9 ± 5.1%, t(4) = 0.7234, p = 0.5095, unpaired t test, n = 3), suggesting that knockdown of AT2R(s) was specific to the CeA. To ascertain the contribution of AT2R(s) to anxiety-like behavior, mice were tested in the EPM, OFA, and GCT as done previously. Contrary to exciting CeAAT2R, deleting AT2R(s) from the CeA produced effects consistent with an anxiogenic phenotype (Fig. 8D–F⇓). Specifically, AT2Rflox mice given AAV expressing Cre-recombinase spent significantly less time in the open (t(10) = 3.9, p = 0.0031, unpaired t test, n = 5–7) but more time in closed arms (t(10) = 3.7, p = 0.0043, unpaired t test, n = 5–7) of the EPM and had increased latency to eat (t(14) = 3.0, p = 0.0112, unpaired t test, n = 7–9) in the GCT; however, control mice and those with AT2R knockdown exhibited similar behaviors in the OFA. These results demonstrate that deletion of AT2R(s) from the CeA increases anxiety-like behavior and further suggest that, under basal conditions, these AT2R(s) promote anxiolysis.

Figure 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 8.

The deletion of AT2R(s) within the CeA is anxiogenic. A, Schematic depicting male AT2R-flox mice that received Cre-inducible AAVs to direct the expression of tdTomato (control; white) or Cre-recombinase and tdTomato (Cre-tdTom; red) to the CeA. B, A representative coronal atlas section and corresponding photomicrograph demonstrating tdTom expression within the CeA. C, RNAscope in situ hybridization showing Agtr2 mRNA colocalization with (left) tdTomato and (right) the cell marker, DAPI, is significantly decreased in the CeA of AT2Rflox mice given AAV expressing Cre-recombinase (Cre-tdTom) relative to those given the control virus (tdTom). The performance of tdTom and Cre-tdTom mice in the (D) EPM, (E) OFA, and (F) GCT. **p < 0.01, ****p < 0.0001; unpaired student t test. n = 3–9.

Figure 9.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 9.

Amplifying the firing of CeAAT2R silences neurons whose activation is coupled to anxiety-like behavior and elevated blood pressure. The firing of CeAAT2R is elicited by way of activating AT2R(s) using a specific agonist, C21, or by way of optogenetic stimulation of ChR2. The majority of CeAAT2R form GABAergic inhibitory synapses onto neighboring neurons that lack AT2R(s). The activity of such CeA neurons has been previously linked to anxiety-like behavior, via projections to areas like the periaqueductal gray (PAG), lateral hypothalamus (LH), and locus ceruleus (LC; Viviani et al., 2011; Paretkar and Dimitrov, 2018; Weera et al., 2021), and elevated blood pressure via projections to areas like the nucleus of the solitary tract (NTS; Saha, 2005). Here, we find that excitation of CeAAT2R leads to the release of GABA, which inhibits neighboring neurons in the CeA and quells their influence over effector nuclei that promote anxiety and sympathetically mediated vasoconstriction. While the present studies do not uncover the projection phenotypes of the non-AT2R neurons within the CeA that receive inhibitory input from CeAAT2R, they do reveal that subsets of CeAAT2R send projections to areas outside the CeA that are implicated in these processes. The present studies also reveal that the CeAAT2R that project to the NTS, in particular, are pressor neurons. Figure generated using BioRender.com.

Discussion

The current study reveals a unique population of neurons whose excitation reduces blood pressure and anxiety-like behavior (Fig. 9). These neurons synthesize AT2R(s) and reside in the CeA and are therefore identified as CeAAT2R. While some CeAAT2R synthesize glutamate and send axonal connections to distal brain nuclei, the majority of CeAAT2R are GABAergic neurons. Pharmacological stimulation of AT2R(s) in the CeA lowers blood pressure, and this effect can be recapitulated by optogenetic excitation of CeAAT2R. The lowered blood pressure that accompanies optogenetic excitation of CeAAT2R is mediated by GABAergic inhibition of neighboring neurons in the amygdala, and this reduces sympathetic drive to cardiovascular tissues. Remarkably, stimulation of AT2R(s) or optogenetic excitation of CeAAT2R also decreases anxiety-like behavior; however, ablating AT2R(s) specifically in the CeA produces the opposite effect. Collectively, these results suggest that excitation of CeAAT2R elicits hypotension and anxiolysis (Fig. 9). The implication is that CeAAT2R exerts top-down control over mind-to-body communication that promotes resiliency or susceptibility to stress-related disease.

The CeA has long been implicated in the autonomic and behavioral responses to psychological stress (Davis and Shi, 1999; Saha, 2005). The CeA is mostly composed of GABAergic neurons that form robust local connections within the extended amygdala (Cassell et al., 1999). Additional subsets of CeA neurons send projections to fore-, mid-, and hindbrain nuclei that regulate autonomic outflow to peripheral organs (Saha, 2005). We found that most CeAAT2R synthesize GABA and function as inhibitory neurons that make local connections within the CeA; however, some CeAAT2R send axonal projections to fore-, mid-, and hindbrain nuclei that regulate autonomic outflow. Thus, CeAAT2R exhibit neurochemical and structural characteristics of prototypical CeA neurons.

The connectivity of the CeA, in conjunction with an established role of the amygdala in the processing of emotional stimuli, has led to the notion that the CeA exerts descending control over somatic manifestations of fear and anxiety. In support of this notion, electrical stimulation of the CeA elevates blood pressure and heart rate (Hilton and Zbrozyna, 1963; Stock et al., 1978, 1981), and this effect is thought to be mediated by GABAergic neurons with distal projections to the hindbrain (Saha et al., 2000; Saha, 2005). Conversely, electrical stimulation of the CeA has also been found to lower blood pressure (Gelsema et al., 1987; Iwata et al., 1987), and this effect is believed to be mediated by the local release of GABA (Ciriello and Roder, 1999). These collective results indicate that excitation of the CeA may elicit pressor or depressor responses depending on which connections and neurotransmitters are engaged. Analogous to these prior studies, we found that excitation of CeAAT2R elicits pressor or depressor responses that appear to be circuit specific. That is, we found that excitation of axon terminals in the NTS originating from CeAAT2R elicited pressor, but excitation of the soma of CeAAT2R elicited depressor responses. Regarding the depressor response, neurons of the CeA with direct projections to the hindbrain are densely innervated by GABAergic synapses, suggesting that local connections within the CeA tonically inhibit sympathetic outflow to cardiovascular tissues (Sun et al., 1994). Consistent with this interpretation, our experiments found that delivery of a GABA receptor antagonist into the CeA produced a transient increase in blood pressure. Furthermore, we determined that functional GABAergic synapses were also required for the lowered blood pressure that accompanies excitation of CeAAT2R. These results suggest that CeAAT2R exert an inhibitory influence over descending pathways that evoke somatic responses to stress.

In addition to somatic responses, neurons within the CeA have long been implicated in the control of anxiety-like behavior (Walker et al., 2009), and our results indicate that CeAAT2R likely mediate these effects. We found that chronic central administration of the AT2R agonist, C21, reduces anxiety-like behavior, and our follow-up experiments determined that in vivo optogenetic excitation of CeAAT2R is potently anxiolytic. Prior research found that whole body deletion of the AT2R in mice results in an anxiogenic phenotype (Ichiki et al., 1995; Okuyama et al., 1999). Interestingly, we recapitulated this anxiogenic phenotype by selectively ablating AT2R(s) within the CeA. That is, opposite to what we observed with excitation of CeAAT2R, knockdown of AT2R(s) specifically within the CeA increases anxiety-like behavior. Taken together, these results demonstrate that agonism of the AT2R or excitation of CeAAT2R suppresses anxiety-like behavior and AT2R(s) within the CeA are necessary to maintain basal levels of anxiolysis.

Behavioral manifestations of anxiety also appear to be controlled by CeA output neurons that are under tonic inhibition. Studies by Tye et al. (2011) used in vivo optogenetics in mice to manipulate excitatory inputs to GABAergic neurons of the CeA. Driving these excitatory inputs was anxiolytic but inhibiting them increased anxiety (Tye et al., 2011). Here, our in vitro electrophysiological recordings found that optogenetic excitation of CeAAT2R directly evoked GABA-mediated iPSCs recorded from neighboring, non-CeAAT2R neurons. These responses were observed in every patched non-CeAAT2R neuron, and evoked responses were of high fidelity, even at a stimulation frequency of 10 Hz, altogether implying that, within the CeA, a local synaptic GABAergic microcircuit may mediate anxiolytic and autonomic output. Consistent with this notion, complimentary in vivo optogenetic experiments found that excitation of CeAAT2R suppressed anxiety-like behavior and lowered blood pressure, an effect that was abolished by the local blockade of GABA receptors. These results, in conjunction with prior research, suggests that excitation of CeAAT2R suppresses the activation of amygdalar outputs that heighten stress reactivity. Accordingly, we propose that AT2R(s) demarcate a subset of GABAergic neurons that potently inhibit projections from the extended amygdala that drive physiological and behavioral responses to stress. The implication is that CeAAT2R may become compromised during the onset of stress-related disease or conversely, may be recruited by therapeutics that provide stress relief. Given that CeAAT2R mediate blood pressure, as well as anxiety, future studies implementing animal models of comorbid affective and cardiovascular disorders may shed insight on the utility of targeting CeAAT2R to understand and alleviate stress-related pathologies.

Limitations and future directions

Although the current study tests hypotheses by implementing a multifaceted approach, there are limitations to consider. Many of the experiments relied on administration of viruses into a discrete region of the mouse brain (i.e., CeA). Cases deemed “hits” represent microinjections that were highly localized to the CeA; however, it is challenging to restrict microinjections exclusively within the confines of the CeA. In some instances, we did observe sparse labeling of somas in adjacent brain nuclei. To account for this limitation, we confirmed that brain nuclei targeted by axons arising from CeAAT2R (e.g., medial amygdala, subthalamic nucleus, and lateral preoptic area) were previously determined to receive projections from the CeA with methodology (e.g., virally mediated neuronal tract tracing) similar to that used in the present study (Han et al., 2017; Weera et al., 2023). Regarding in vivo optogenetic experiments, fiber optics were placed immediately dorsal to the target nucleus, which mitigates off-target stimulation that may have resulted from the spread of virus outside of the CeA. Another limitation relates to the recording of cardiovascular parameters under general anesthesia. We did not observe changes in blood pressure during optogenetic stimulation of fibers in the PAG or the BNST that originated from CeAAT2R. Despite these null findings, it is possible that projections from CeAAT2R to the PAG and/or BNST mediate cardiovascular function in conscious animals. This is especially likely under stressful conditions. The BNST and PAG are heavily implicated in cardiovascular and behavioral stress responses (Jaramillo et al., 2020; Maita et al., 2022; Matsuyama and Horiuchi, 2024). For example, the PAG, in particular, is known to mediate vasomotor responses evoked by social defeat stress (Matsuyama and Horiuchi, 2024). Finally, our studies largely interrogate the role that CeAAT2R play in mediating blood pressure and anxiety-like behavior by way of conducting sufficiency experiments (i.e., optogenetic excitation; AT2R stimulation). We did perform loss of function experiments that revealed the anxiogenic effects of knocking down AT2R(s) within the CeA. However, experiments that evaluate the necessity of the CeAAT2R in the control of blood pressure by way of optogenetically inhibiting CeAAT2R were not conducted. Consequently, the role that CeAAT2R play in the physiological regulation of blood pressure is less clear. Inhibitory optogenetic experiments are intriguing future directions, as are follow-up studies that parse the up- and downstream neural circuits mediating the anxiolytic and depressor effects associated with excitation of CeAAT2R and their AT2R(s).

Footnotes

  • This work was supported by the National Institutes of Health: R35HL150750 (E.G.K.), R01HL145028 (A.D.K.); AHA 23POST1020034 and K99HL175100 (K.E.).

  • The authors declare no competing financial interests.

  • Correspondence should be addressed to Eric G. Krause at ekrause{at}gsu.edu or Annette D. de Kloet at adekloet{at}gsu.edu.

SfN exclusive license.

References

  1. ↵
    1. Bregonzio C,
    2. Seltzer A,
    3. Armando I,
    4. Pavel J,
    5. Saavedra JM
    (2008) Angiotensin II AT(1) receptor blockade selectively enhances brain AT(2) receptor expression, and abolishes the cold-restraint stress-induced increase in tyrosine hydroxylase mRNA in the locus coeruleus of spontaneously hypertensive rats. Stress 11:457–466. https://doi.org/10.1080/10253890801892040 pmid:18609298
    OpenUrlCrossRefPubMed
  2. ↵
    1. Cassell MD,
    2. Freedman LJ,
    3. Shi C
    (1999) The intrinsic organization of the central extended amygdala. Ann N Y Acad Sci 877:217–241. https://doi.org/10.1111/j.1749-6632.1999.tb09270.x
    OpenUrlCrossRefPubMed
  3. ↵
    1. Chappell MC
    (2016) Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute? Am J Physiol Heart Circ Physiol 310:H137–H152. https://doi.org/10.1152/ajpheart.00618.2015 pmid:26475588
    OpenUrlCrossRefPubMed
  4. ↵
    1. Chung SC,
    2. Brooks MM,
    3. Rai M,
    4. Balk JL,
    5. Rai S
    (2012) Effect of Sahaja yoga meditation on quality of life, anxiety, and blood pressure control. J Altern Complement Med 18:589–596. https://doi.org/10.1089/acm.2011.0038
    OpenUrlCrossRefPubMed
  5. ↵
    1. Ciriello J,
    2. Roder S
    (1999) GABAergic effects on the depressor responses elicited by stimulation of central nucleus of the amygdala. Am J Physiol 276:H242–H247. https://doi.org/10.1152/ajpheart.1999.276.1.H242
    OpenUrl
  6. ↵
    1. Curtin SC,
    2. Tejada-Vera B,
    3. Bastian BA
    (2023) Deaths: leading causes for 2020. Natl Vital Stat Rep 72:1–115.
    OpenUrlPubMed
  7. ↵
    1. Davern PJ,
    2. Chen D,
    3. Head GA,
    4. Chavez CA,
    5. Walther T,
    6. Mayorov DN
    (2009) Role of angiotensin II type 1A receptors in cardiovascular reactivity and neuronal activation after aversive stress in mice. Hypertension 54:1262–1268. https://doi.org/10.1161/HYPERTENSIONAHA.109.139741
    OpenUrlCrossRef
  8. ↵
    1. Davis M,
    2. Shi C
    (1999) The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety? Ann N Y Acad Sci 877:281–291. https://doi.org/10.1111/j.1749-6632.1999.tb09273.x
    OpenUrlCrossRefPubMed
  9. ↵
    1. deBoer RW,
    2. Karemaker JM,
    3. Strackee J
    (1987) Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. Am J Physiol 253:H680–H689. https://doi.org/10.1152/ajpheart.1987.253.3.H680
    OpenUrlCrossRef
  10. ↵
    1. de Kloet AD, et al.
    (2017) A unique “angiotensin-sensitive” neuronal population coordinates neuroendocrine, cardiovascular, and behavioral responses to stress. J Neurosci 37:3478–3490. https://doi.org/10.1523/JNEUROSCI.3674-16.2017 pmid:28219987
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. de Kloet AD,
    2. Pitra S,
    3. Wang L,
    4. Hiller H,
    5. Pioquinto DJ,
    6. Smith JA,
    7. Sumners C,
    8. Stern JE,
    9. Krause EG
    (2016a) Angiotensin type-2 receptors influence the activity of vasopressin neurons in the paraventricular nucleus of the hypothalamus in male mice. Endocrinology 157:3167–3180. https://doi.org/10.1210/en.2016-1131 pmid:27267713
    OpenUrlCrossRefPubMed
  12. ↵
    1. de Kloet AD,
    2. Wang L,
    3. Ludin JA,
    4. Smith JA,
    5. Pioquinto DJ,
    6. Hiller H,
    7. Steckelings UM,
    8. Scheuer DA,
    9. Sumners C,
    10. Krause EG
    (2016b) Reporter mouse strain provides a novel look at angiotensin type-2 receptor distribution in the central nervous system. Brain Struct Funct 221:891–912. https://doi.org/10.1007/s00429-014-0943-1 pmid:25427952
    OpenUrlCrossRefPubMed
  13. ↵
    1. Elsaafien K,
    2. Harden SW,
    3. Johnson DN,
    4. Kimball AK,
    5. Sheng W,
    6. Smith JA,
    7. Scott KA,
    8. Frazier CJ,
    9. de Kloet AD,
    10. Krause EG
    (2022) A novel organ-specific approach to selectively target sensory afferents innervating the aortic arch. Front Physiol 13:417. https://doi.org/10.3389/fphys.2022.841078 pmid:35399269
    OpenUrlPubMed
  14. ↵
    1. Elsaafien K,
    2. Kirchner MK,
    3. Mohammed M,
    4. Eikenberry SA,
    5. West C,
    6. Scott KA,
    7. de Kloet AD,
    8. Stern JE,
    9. Krause EG
    (2021) Identification of novel cross-talk between the neuroendocrine and autonomic stress axes controlling blood pressure. J Neurosci 41:4641–4657. https://doi.org/10.1523/JNEUROSCI.0251-21.2021 pmid:33858944
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Frazier CJ,
    2. Harden SW,
    3. Alleyne AR,
    4. Mohammed M,
    5. Sheng W,
    6. Smith JA,
    7. Elsaafien K,
    8. Spector EA,
    9. Johnson DN,
    10. Scott KA
    (2021) An angiotensin-responsive connection from the lamina terminalis to the paraventricular nucleus of the hypothalamus evokes vasopressin secretion to increase blood pressure in mice. J Neurosci 41:1429–1442. https://doi.org/10.1523/JNEUROSCI.1600-20.2020 pmid:33328294
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Gelsema AJ,
    2. McKitrick DJ,
    3. Calaresu FR
    (1987) Cardiovascular responses to chemical and electrical stimulation of amygdala in rats. Am J Physiol 253:R712–R718. https://doi.org/10.1152/ajpregu.1987.253.5.R712
    OpenUrl
  17. ↵
    1. Gianaros PJ,
    2. Sheu LK,
    3. Matthews KA,
    4. Jennings JR,
    5. Manuck SB,
    6. Hariri AR
    (2008) Individual differences in stressor-evoked blood pressure reactivity vary with activation, volume, and functional connectivity of the amygdala. J Neurosci 28:990–999. https://doi.org/10.1523/JNEUROSCI.3606-07.2008 pmid:18216206
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Ginty AT,
    2. Kraynak TE,
    3. Fisher JP,
    4. Gianaros PJ
    (2017) Cardiovascular and autonomic reactivity to psychological stress: neurophysiological substrates and links to cardiovascular disease. Auton Neurosci 207:2–9. https://doi.org/10.1016/j.autneu.2017.03.003 pmid:28391987
    OpenUrlCrossRefPubMed
  19. ↵
    1. Gonzalez AD, et al.
    (2012) Distribution of angiotensin type 1a receptor-containing cells in the brains of bacterial artificial chromosome transgenic mice. Neuroscience 226:489–509. https://doi.org/10.1016/j.neuroscience.2012.08.039 pmid:22922351
    OpenUrlCrossRefPubMed
  20. ↵
    1. Goyal M, et al.
    (2014) Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Intern Med 174:357–368. https://doi.org/10.1001/jamainternmed.2013.13018 pmid:24395196
    OpenUrlCrossRefPubMed
  21. ↵
    1. Han W,
    2. Tellez LA,
    3. Rangel MJ,
    4. Motta SC,
    5. Zhang X,
    6. Perez IO,
    7. Canteras NS,
    8. Shammah-Lagnado SJ,
    9. van den Pol AN,
    10. de Araujo IE
    (2017) Integrated control of predatory hunting by the central nucleus of the amygdala. Cell 168:311–324.e18. https://doi.org/10.1016/j.cell.2016.12.027 pmid:28086095
    OpenUrlCrossRefPubMed
  22. ↵
    1. Hernáth F,
    2. Schlett K,
    3. Szücs A
    (2019) Alternative classifications of neurons based on physiological properties and synaptic responses, a computational study. Sci Rep 9:13096. https://doi.org/10.1038/s41598-019-49197-8 pmid:31511545
    OpenUrlCrossRefPubMed
  23. ↵
    1. Hilton SM,
    2. Zbrozyna AW
    (1963) Amygdaloid region for defence reactions and its efferent pathway to the brain stem. J Physiol 165:160–173. https://doi.org/10.1113/jphysiol.1963.sp007049 pmid:13954608
    OpenUrlCrossRefPubMed
  24. ↵
    1. Ichiki T,
    2. Labosky PA,
    3. Shiota C,
    4. Okuyama S,
    5. Imagawa Y,
    6. Fogo A,
    7. Niimura F,
    8. Ichikawa I,
    9. Hogan BL,
    10. Inagami T
    (1995) Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377:748–750. https://doi.org/10.1038/377748a0
    OpenUrlCrossRefPubMed
  25. ↵
    1. Iwata J,
    2. Chida K,
    3. LeDoux JE
    (1987) Cardiovascular responses elicited by stimulation of neurons in the central amygdaloid nucleus in awake but not anesthetized rats resemble conditioned emotional responses. Brain Res 418:183–188. https://doi.org/10.1016/0006-8993(87)90978-4
    OpenUrlCrossRefPubMed
  26. ↵
    1. Jaramillo A,
    2. Williford K,
    3. Marshall C,
    4. Winder D,
    5. Centanni S
    (2020) BNST transient activity associates with approach behavior in a stressful environment and is modulated by the parabrachial nucleus. Neurobiol Stress 13:100247. https://doi.org/10.1016/j.ynstr.2020.100247 pmid:33344702
    OpenUrlCrossRefPubMed
  27. ↵
    1. Kral TRA,
    2. Schuyler BS,
    3. Mumford JA,
    4. Rosenkranz MA,
    5. Lutz A,
    6. Davidson RJ
    (2018) Impact of short- and long-term mindfulness meditation training on amygdala reactivity to emotional stimuli. Neuroimage 181:301–313. https://doi.org/10.1016/j.neuroimage.2018.07.013 pmid:29990584
    OpenUrlCrossRefPubMed
  28. ↵
    1. Levine GN, et al.
    (2017) Meditation and cardiovascular risk reduction: a scientific statement from the American Heart Association. J Am Heart Assoc 6:e002218. https://doi.org/10.1161/JAHA.117.002218 pmid:28963100
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Madwed JB,
    2. Albrecht P,
    3. Mark RG,
    4. Cohen RJ
    (1989) Low-frequency oscillations in arterial pressure and heart rate: a simple computer model. Am J Physiol 256:H1573–H1579. https://doi.org/10.1152/ajpheart.1989.256.6.H1573
    OpenUrlCrossRef
  30. ↵
    1. Maita I,
    2. Roepke TA,
    3. Samuels BA
    (2022) Chronic stress-induced synaptic changes to corticotropin-releasing factor-signaling in the bed nucleus of the stria terminalis. Front Behav Neurosci 16:903782. https://doi.org/10.3389/fnbeh.2022.903782 pmid:35983475
    OpenUrlCrossRefPubMed
  31. ↵
    1. Matsuyama M,
    2. Horiuchi J
    (2024) A descending pathway from the lateral/ventrolateral PAG to the rostroventral medulla mediating the vasomotor response evoked by social defeat stress in rats. Am J Physiol Regul Integr Comp Physiol 327:R66–R78. https://doi.org/10.1152/ajpregu.00295.2023
    OpenUrlCrossRefPubMed
  32. ↵
    1. Mendelsohn FA,
    2. Quirion R,
    3. Saavedra JM,
    4. Aguilera G,
    5. Catt KJ
    (1984) Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci U S A 81:1575–1579. https://doi.org/10.1073/pnas.81.5.1575 pmid:6324205
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Mohammed M, et al.
    (2022) Targeting angiotensin type-2 receptors located on pressor neurons in the nucleus of the solitary tract to relieve hypertension in mice. Cardiovasc Res 118:883–896. https://doi.org/10.1093/cvr/cvab085 pmid:33723600
    OpenUrlCrossRefPubMed
  34. ↵
    1. Mohebi R,
    2. Chen C,
    3. Ibrahim NE,
    4. McCarthy CP,
    5. Gaggin HK,
    6. Singer DE,
    7. Hyle EP,
    8. Wasfy JH,
    9. Januzzi JL Jr.
    (2022) Cardiovascular disease projections in the United States based on the 2020 census estimates. J Am Coll Cardiol 80:565–578. https://doi.org/10.1016/j.jacc.2022.05.033 pmid:35926929
    OpenUrlCrossRefPubMed
  35. ↵
    1. Okuyama S,
    2. Sakagawa T,
    3. Chaki S,
    4. Imagawa Y,
    5. Ichiki T,
    6. Inagami T
    (1999) Anxiety-like behavior in mice lacking the angiotensin II type-2 receptor. Brain Res 821:150–159. https://doi.org/10.1016/S0006-8993(99)01098-7
    OpenUrlCrossRefPubMed
  36. ↵
    1. Palta P,
    2. Page G,
    3. Piferi RL,
    4. Gill JM,
    5. Hayat MJ,
    6. Connolly AB,
    7. Szanton SL
    (2012) Evaluation of a mindfulness-based intervention program to decrease blood pressure in low-income African-American older adults. J Urban Health 89:308–316. https://doi.org/10.1007/s11524-011-9654-6 pmid:22302233
    OpenUrlCrossRefPubMed
  37. ↵
    1. Paretkar T,
    2. Dimitrov E
    (2018) The central amygdala corticotropin-releasing hormone (CRH) neurons modulation of anxiety-like behavior and hippocampus-dependent memory in mice. Neuroscience 390:187–197. https://doi.org/10.1016/j.neuroscience.2018.08.019 pmid:30170157
    OpenUrlCrossRefPubMed
  38. ↵
    1. Rátkai A,
    2. Tárnok K,
    3. Aouad HE,
    4. Micska B,
    5. Schlett K,
    6. Szücs A
    (2021) Homeostatic plasticity and burst activity are mediated by hyperpolarization-activated cation currents and T-type calcium channels in neuronal cultures. Sci Rep 11:3236. https://doi.org/10.1038/s41598-021-82775-3 pmid:33547341
    OpenUrlCrossRefPubMed
  39. ↵
    1. Saha S
    (2005) Role of the central nucleus of the amygdala in the control of blood pressure: descending pathways to medullary cardiovascular nuclei. Clin Exp Pharmacol Physiol 32:450–456. https://doi.org/10.1111/j.1440-1681.2005.04210.x
    OpenUrlCrossRefPubMed
  40. ↵
    1. Saha S,
    2. Batten TF,
    3. Henderson Z
    (2000) A GABAergic projection from the central nucleus of the amygdala to the nucleus of the solitary tract: a combined anterograde tracing and electron microscopic immunohistochemical study. Neuroscience 99:613–626. https://doi.org/10.1016/S0306-4522(00)00240-2
    OpenUrlCrossRefPubMed
  41. ↵
    1. Steckelings UM,
    2. Larhed M,
    3. Hallberg A,
    4. Widdop RE,
    5. Jones ES,
    6. Wallinder C,
    7. Namsolleck P,
    8. Dahlof B,
    9. Unger T
    (2011) Non-peptide AT2-receptor agonists. Curr Opin Pharmacol 11:187–192. https://doi.org/10.1016/j.coph.2010.11.002
    OpenUrlCrossRefPubMed
  42. ↵
    1. Steckelings UM,
    2. Widdop RE,
    3. Sturrock ED,
    4. Lubbe L,
    5. Hussain T,
    6. Kaschina E,
    7. Unger T,
    8. Hallberg A,
    9. Carey RM,
    10. Sumners C
    (2022) The angiotensin AT(2) receptor: from a binding site to a novel therapeutic target. Pharmacol Rev 74:1051–1135. https://doi.org/10.1124/pharmrev.120.000281 pmid:36180112
    OpenUrlAbstract/FREE Full Text
  43. ↵
    1. Stock G,
    2. Rupprecht U,
    3. Stumpf H,
    4. Schlor KH
    (1981) Cardiovascular changes during arousal elicited by stimulation of amygdala, hypothalamus and locus coeruleus. J Auton Nerv Syst 3:503–510. https://doi.org/10.1016/0165-1838(81)90083-7
    OpenUrlCrossRefPubMed
  44. ↵
    1. Stock G,
    2. Schlor KH,
    3. Heidt H,
    4. Buss J
    (1978) Psychomotor behaviour and cardiovascular patterns during stimulation of the amygdala. Pflugers Arch 376:177–184. https://doi.org/10.1007/BF00581581
    OpenUrlCrossRefPubMed
  45. ↵
    1. Sumners C, et al.
    (2020) Brain angiotensin type-1 and type-2 receptors: cellular locations under normal and hypertensive conditions. Hypertens Res 43:281–295. https://doi.org/10.1038/s41440-019-0374-8 pmid:31853042
    OpenUrlCrossRefPubMed
  46. ↵
    1. Sun N,
    2. Yi H,
    3. Cassell MD
    (1994) Evidence for a GABAergic interface between cortical afferents and brainstem projection neurons in the rat central extended amygdala. J Comp Neurol 340:43–64. https://doi.org/10.1002/cne.903400105
    OpenUrlCrossRefPubMed
  47. ↵
    1. Tasic T,
    2. Djordjevic DM,
    3. De Luka SR,
    4. Trbovich AM,
    5. Japundzic-Zigon N
    (2017) Static magnetic field reduces blood pressure short-term variability and enhances baro-receptor reflex sensitivity in spontaneously hypertensive rats. Int J Radiat Biol 93:527–534. https://doi.org/10.1080/09553002.2017.1276307
    OpenUrlCrossRefPubMed
  48. ↵
    1. Tawakol A, et al.
    (2017) Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. Lancet 389:834–845. https://doi.org/10.1016/S0140-6736(16)31714-7
    OpenUrlCrossRefPubMed
  49. ↵
    1. Tsao CW, et al.
    (2023) Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation 147:e93–e621. https://doi.org/10.1161/CIR.0000000000001123
    OpenUrlPubMed
  50. ↵
    1. Tye KM,
    2. Prakash R,
    3. Kim SY,
    4. Fenno LE,
    5. Grosenick L,
    6. Zarabi H,
    7. Thompson KR,
    8. Gradinaru V,
    9. Ramakrishnan C,
    10. Deisseroth K
    (2011) Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 471:358–362. https://doi.org/10.1038/nature09820 pmid:21389985
    OpenUrlCrossRefPubMed
  51. ↵
    1. Viviani D,
    2. Charlet A,
    3. van den Burg E,
    4. Robinet C,
    5. Hurni N,
    6. Abatis M,
    7. Magara F,
    8. Stoop R
    (2011) Oxytocin selectively gates fear responses through distinct outputs from the central amygdala. Science 333:104–107. https://doi.org/10.1126/science.1201043
    OpenUrlAbstract/FREE Full Text
  52. ↵
    1. Walker DL,
    2. Miles LA,
    3. Davis M
    (2009) Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses. Prog Neuropsychopharmacol Biol Psychiatry 33:1291–1308. https://doi.org/10.1016/j.pnpbp.2009.06.022 pmid:19595731
    OpenUrlCrossRefPubMed
  53. ↵
    1. Wang L,
    2. Hiller H,
    3. Smith JA,
    4. de Kloet AD,
    5. Krause EG
    (2016) Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus control cardiovascular reactivity and anxiety-like behavior in male mice. Physiol Genomics 48:667–676. https://doi.org/10.1152/physiolgenomics.00029.2016 pmid:27468749
    OpenUrlCrossRefPubMed
  54. ↵
    1. Weera MM,
    2. Shackett RS,
    3. Kramer HM,
    4. Middleton JW,
    5. Gilpin NW
    (2021) Central amygdala projections to lateral hypothalamus mediate avoidance behavior in rats. J Neurosci 41:61–72. https://doi.org/10.1523/JNEUROSCI.0236-20.2020 pmid:33188067
    OpenUrlAbstract/FREE Full Text
  55. ↵
    1. Weera MM,
    2. Webster DA,
    3. Shackett RS,
    4. Benvenuti F,
    5. Middleton JW,
    6. Gilpin NW
    (2023) Traumatic stress-induced increases in anxiety-like behavior and alcohol self-administration are mediated by central amygdala CRF1 neurons that project to the lateral hypothalamus. J Neurosci 43:8690–8699. https://doi.org/10.1523/JNEUROSCI.1414-23.2023 pmid:37932105
    OpenUrlAbstract/FREE Full Text
  56. ↵
    1. Yu Z,
    2. Kisner A,
    3. Bhatt A,
    4. Polter AM,
    5. Marvar PJ
    (2023) Central amygdala angiotensin type 1 receptor (Agtr1) expressing neurons contribute to fear extinction. Neuropharmacology 229:109460. https://doi.org/10.1016/j.neuropharm.2023.109460
    OpenUrlCrossRefPubMed
  57. ↵
    1. Yu Z,
    2. Swiercz AP,
    3. Moshfegh CM,
    4. Hopkins L,
    5. Wiaderkiewicz J,
    6. Speth RC,
    7. Park J,
    8. Marvar PJ
    (2019) Angiotensin II type 2 receptor-expressing neurons in the central amygdala influence fear-related behavior. Biol Psychiatry 86:899–909. https://doi.org/10.1016/j.biopsych.2019.05.027
    OpenUrlCrossRefPubMed
  58. ↵
    1. Yusuf S, et al.
    (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937–952. https://doi.org/10.1016/S0140-6736(04)17018-9
    OpenUrlCrossRefPubMed
  59. ↵
    1. Zhang W,
    2. Zhang N,
    3. Sakurai T,
    4. Kuwaki T
    (2009) Orexin neurons in the hypothalamus mediate cardiorespiratory responses induced by disinhibition of the amygdala and bed nucleus of the stria terminalis. Brain Res 1262:25–37. https://doi.org/10.1016/j.brainres.2009.01.022
    OpenUrlCrossRefPubMed
  60. ↵
    1. Zhu M,
    2. Sumners C,
    3. Gelband CH,
    4. Posner P
    (2001) Chronotropic effect of angiotensin II via type 2 receptors in rat brain neurons. J Neurophysiol 85:2177–2183. https://doi.org/10.1152/jn.2001.85.5.2177
    OpenUrlCrossRefPubMed
Back to top

In this issue

The Journal of Neuroscience: 45 (12)
Journal of Neuroscience
Vol. 45, Issue 12
19 Mar 2025
  • Table of Contents
  • About the Cover
  • Index by author
  • Masthead (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Neurons of the Central Nucleus of the Amygdala That Express Angiotensin Type 2 Receptors Couple Lowered Blood Pressure with Anxiolysis in Male Mice
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Neurons of the Central Nucleus of the Amygdala That Express Angiotensin Type 2 Receptors Couple Lowered Blood Pressure with Anxiolysis in Male Mice
Khalid Elsaafien, Matthew K. Kirchner, Karen A. Scott, Eliot A. Spector, Francesca E. Mowry, Colin Sumners, Javier E. Stern, Annette D. de Kloet, Eric G. Krause
Journal of Neuroscience 19 March 2025, 45 (12) e1482242025; DOI: 10.1523/JNEUROSCI.1482-24.2025

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Neurons of the Central Nucleus of the Amygdala That Express Angiotensin Type 2 Receptors Couple Lowered Blood Pressure with Anxiolysis in Male Mice
Khalid Elsaafien, Matthew K. Kirchner, Karen A. Scott, Eliot A. Spector, Francesca E. Mowry, Colin Sumners, Javier E. Stern, Annette D. de Kloet, Eric G. Krause
Journal of Neuroscience 19 March 2025, 45 (12) e1482242025; DOI: 10.1523/JNEUROSCI.1482-24.2025
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • Peer Review
  • PDF

Keywords

  • affective
  • autonomic
  • depression
  • hypertension
  • meditation
  • stress

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Articles

  • Chemogenetic disruption of monkey perirhinal neurons projecting to rostromedial caudate impairs associative learning
  • Specializations in amygdalar and hippocampal innervation of the primate nucleus accumbens shell
  • “What” and “When” Predictions Jointly Modulate Speech Processing
Show more Research Articles

Systems/Circuits

  • Chemogenetic disruption of monkey perirhinal neurons projecting to rostromedial caudate impairs associative learning
  • Specializations in amygdalar and hippocampal innervation of the primate nucleus accumbens shell
  • Neuronal Synchronization and Bidirectional Activity Spread Explain Efficient Swimming in a Whole-Body Model of Hydrozoan Jellyfish
Show more Systems/Circuits
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.